×
About 4,636 results

ALLMedicine™ Anal Cancer Center

Research & Reviews  2,119 results

Anal cytology and high-risk human papilloma virus testing in atypical squamous categori...
https://doi.org/10.1002/dc.24740
Diagnostic Cytopathology; Cimic A, Saqi A

Apr 19th, 2021 - Anal squamous cell carcinoma is relatively rare, but its incidence and mortality have been increasing worldwide. While anal cytology is a sensitive cancer screening modality, its specificity is low, and data for concurrent high-risk human papillom...

HRA-Based Anal Cancer Surveillance and Women.
https://doi.org/10.1097/DCR.0000000000002079
Diseases of the Colon and Rectum; Barnell G, Shapiro L et. al.

Apr 9th, 2021 - HRA-Based Anal Cancer Surveillance and Women.|2021|Barnell G,Shapiro L,Lee S,|

Anal cancer screening and prevention: A review for dermatologists.
https://doi.org/10.1111/jdv.17263
Journal of the European Academy of Dermatology and Venere... McGovern J, Fuller C et. al.

Apr 2nd, 2021 - The incidence of and mortality from anal cancer, predominantly squamous cell carcinoma (SCC), have been increasing since the 1980s, during an era when many common malignancies have seen decreases in mortality. Dermatologists may be more likely to ...

Predicting outcomes in anal cancer patients using multi-centre data and distributed lea...
https://doi.org/10.1016/j.radonc.2021.03.013
Radiotherapy and Oncology : Journal of the European Socie... Choudhury A, Theophanous S et. al.

Mar 23rd, 2021 - Predicting outcomes is challenging in rare cancers. Single-institutional datasets are often small and multi-institutional data sharing is complex. Distributed learning allows machine learning models to use data from multiple institutions without e...

see more →

Guidelines  23 results

Anal Cancer Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/anal/hp/anal-treatment-pdq?cid=eb_govdel
National Cancer Institute

Jan 13th, 2021 - Incidence and Mortality Estimated new cases and deaths from anal, anal canal, and anorectal cancer in the United States in 2021:[1]

Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer
http://www.jnccn.org/content/17/1/29.abstract
Wang,Y.,et al

Jan 16th, 2019 - Background: Chemotherapy with or without pelvic radiotherapy (RT) is included in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for metastatic anal cancer (MAC), despite limited clinical evidence for RT in this setting. In add...

Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in ...
https://doi.org/10.6004/jnccn.2018.0066
Journal of the National Comprehensive Cancer Network : JN... Reid E, Suneja G et. al.

Aug 13th, 2018 - People living with HIV (PLWH) are diagnosed with cancer at an increased rate over the general population and generally have a higher mortality due to delayed diagnoses, advanced cancer stage, comorbidities, immunosuppression, and cancer treatment ...

Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
https://doi.org/10.6004/jnccn.2018.0060
Journal of the National Comprehensive Cancer Network : JN... Benson AB, Venook AP et. al.

Jul 14th, 2018 - The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain les...

The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squa...
https://www.fascrs.org/sites/default/files/downloads/publication/cpg_anal_squamous_cell_cancers_2018.pdf
David B. Stewart

Jun 30th, 2018 - Squamous cell cancers of the anal canal and perianal region remain one of the least common malignancies arising from the alimentary tract. As of 2016, it is estimated that 8200 new cases of squamous cell cancers of the anus were diagnosed in the U.

see more →

Drugs  3 results see all →

Clinicaltrials.gov  2,309 results

Anal cytology and high-risk human papilloma virus testing in atypical squamous categori...
https://doi.org/10.1002/dc.24740
Diagnostic Cytopathology; Cimic A, Saqi A

Apr 19th, 2021 - Anal squamous cell carcinoma is relatively rare, but its incidence and mortality have been increasing worldwide. While anal cytology is a sensitive cancer screening modality, its specificity is low, and data for concurrent high-risk human papillom...

HRA-Based Anal Cancer Surveillance and Women.
https://doi.org/10.1097/DCR.0000000000002079
Diseases of the Colon and Rectum; Barnell G, Shapiro L et. al.

Apr 9th, 2021 - HRA-Based Anal Cancer Surveillance and Women.|2021|Barnell G,Shapiro L,Lee S,|

Anal cancer screening and prevention: A review for dermatologists.
https://doi.org/10.1111/jdv.17263
Journal of the European Academy of Dermatology and Venere... McGovern J, Fuller C et. al.

Apr 2nd, 2021 - The incidence of and mortality from anal cancer, predominantly squamous cell carcinoma (SCC), have been increasing since the 1980s, during an era when many common malignancies have seen decreases in mortality. Dermatologists may be more likely to ...

Predicting outcomes in anal cancer patients using multi-centre data and distributed lea...
https://doi.org/10.1016/j.radonc.2021.03.013
Radiotherapy and Oncology : Journal of the European Socie... Choudhury A, Theophanous S et. al.

Mar 23rd, 2021 - Predicting outcomes is challenging in rare cancers. Single-institutional datasets are often small and multi-institutional data sharing is complex. Distributed learning allows machine learning models to use data from multiple institutions without e...

see more →

News  167 results

The Vanguard of HIV Care: Don't Forget This Screening
https://www.medscape.com/viewarticle/946148

Feb 21st, 2021 - HIV-positive patients who are adherent with antiretroviral medications are achieving undetectable or very low levels of HIV viremia and living longer. In response, clinical care is continually adapting to the dramatically altered natural history o...

Anal Cancer Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/anal/hp/anal-treatment-pdq?cid=eb_govdel
National Cancer Institute

Jan 13th, 2021 - Incidence and Mortality Estimated new cases and deaths from anal, anal canal, and anorectal cancer in the United States in 2021:[1]

'Reshaping' Radiotherapy May Reduce Female Sexual Dysfunction
https://www.medscape.com/viewarticle/940447

Nov 4th, 2020 - Radiotherapy plays an important role in the treatment of anal cancer, but many female survivors treated with pelvic radiotherapy develop long-term sexual problems. A new study shows that it is possible to reduce the dose of radiation reaching the ...

Combo Carboplatin/Paclitaxel New Standard of Care for Anal Cancer
https://www.staging.medscape.com/viewarticle/932971

Jun 24th, 2020 - UPDATED with comments  June 25, 2020 // This story has been updated with comments about the study from Dr Michael Buckstein. Carboplatin plus paclitaxel should now be considered the standard of care for patients with advanced anal cancer, in place...

Carboplatin Plus Paclitaxel New Standard for Advanced Anal Cancer
https://www.staging.medscape.com/viewarticle/932785

Jun 23rd, 2020 - NEW YORK (Reuters Health) - In patients with advanced anal cancer, carboplatin plus paclitaxel was associated with less toxicity and a trend toward longer survival compared with cisplatin and fluorouracil (FU), in a midstage study. These results "...

see more →

Patient Education  15 results see all →